Thyrocare Technologies Share Price
Sector: Healthcare Facilities
644.70 +4.05 (0.63%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
637.85
Today’s High
655.55
52 Week Low
511
52 Week High
722
643.10 +2.35 (0.37%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
637.75
Today’s High
655
52 Week Low
506.8
52 Week High
722.65
Key Metrics
- Market Cap (In Cr) 3392.92
- Beta 0.58
- Div. Yield (%) 2.81
- P/B 6.44
- TTM P/E 43.9
- Peg Ratio 1.95
- Sector P/E 26.76
- D/E 0.08
- Open Price 651.9
- Prev Close 640.65
Thyrocare Technologies Analysis
Price Analysis
-
1 Week2.24%
-
3 Months4.07%
-
6 Month-3.2%
-
YTD-0.44%
-
1 Year22.73%
Risk Meter
- 29% Low risk
- 29% Moderate risk
- 29% Balanced Risk
- 29% High risk
- 29% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 1
- 1
- 1
- 1
- Buy
- 0
- 0
- 0
- 0
- Hold
- 0
- 0
- 0
- 0
- Sell
- 0
- 0
- 0
- 0
- Strong Sell
- 0
- 0
- 0
- 0
- Total
- 1
- 1
- 1
- 1
Thyrocare Technologies News
Thyrocare Technologies may see 20% upside; ICICI Securities upgrades stock
2 min read . 14 Dec 2023Thyrocare Technologies Q4 earnings: Net profit tumbles 36% to ₹21 Cr, revenue up 4%
1 min read . 23 May 2023Thyrocare Technologies Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 571.88
- Selling/ General/ Admin Expenses Total
- 107.86
- Depreciation/ Amortization
- 47.01
- Other Operating Expenses Total
- 159.89
- Total Operating Expense
- 481.46
- Operating Income
- 90.42
- Net Income Before Taxes
- 95.98
- Net Income
- 70.76
- Diluted Normalized EPS
- 13.4
- Period
- 2024
- Total Assets
- 643.88
- Total Liabilities
- 117.11
- Total Equity
- 526.77
- Tangible Book Valueper Share Common Eq
- 79.74
- Period
- 2024
- Cashfrom Operating Activities
- 167.62
- Cashfrom Investing Activities
- -91.29
- Cashfrom Financing Activities
- -84.8
- Net Changein Cash
- -8.47
- Period
- 2023
- Total Revenue
- 526.67
- Selling/ General/ Admin Expenses Total
- 238.71
- Depreciation/ Amortization
- 38.71
- Other Operating Expenses Total
- 0.42
- Total Operating Expense
- 444.48
- Operating Income
- 82.19
- Net Income Before Taxes
- 88.59
- Net Income
- 64.49
- Diluted Normalized EPS
- 12.25
- Period
- 2023
- Total Assets
- 632.72
- Total Liabilities
- 98.42
- Total Equity
- 534.3
- Tangible Book Valueper Share Common Eq
- 81.85
- Period
- 2023
- Cashfrom Operating Activities
- 129.31
- Cashfrom Investing Activities
- -38.99
- Cashfrom Financing Activities
- -86.18
- Net Changein Cash
- 4.14
- Period
- 2022
- Total Revenue
- 588.86
- Selling/ General/ Admin Expenses Total
- 177.31
- Depreciation/ Amortization
- 33.87
- Other Operating Expenses Total
- 4.17
- Total Operating Expense
- 385.71
- Operating Income
- 203.15
- Net Income Before Taxes
- 227.72
- Net Income
- 176.14
- Diluted Normalized EPS
- 32.93
- Period
- 2022
- Total Assets
- 607.66
- Total Liabilities
- 81.09
- Total Equity
- 526.57
- Tangible Book Valueper Share Common Eq
- 80.42
- Period
- 2022
- Cashfrom Operating Activities
- 113.41
- Cashfrom Investing Activities
- -23.57
- Cashfrom Financing Activities
- -89.41
- Net Changein Cash
- 0.43
- Period
- 2021
- Total Revenue
- 494.62
- Selling/ General/ Admin Expenses Total
- 155.61
- Depreciation/ Amortization
- 30.28
- Other Operating Expenses Total
- 2.51
- Total Operating Expense
- 351.86
- Operating Income
- 142.76
- Net Income Before Taxes
- 152.47
- Net Income
- 113.15
- Diluted Normalized EPS
- 20.55
- Period
- 2021
- Total Assets
- 545.8
- Total Liabilities
- 118.52
- Total Equity
- 427.28
- Tangible Book Valueper Share Common Eq
- 61.66
- Period
- 2021
- Cashfrom Operating Activities
- 116.04
- Cashfrom Investing Activities
- -50.23
- Cashfrom Financing Activities
- -61.57
- Net Changein Cash
- 4.24
- Period
- 2020
- Total Revenue
- 433.2
- Selling/ General/ Admin Expenses Total
- 138.6
- Depreciation/ Amortization
- 31.91
- Other Operating Expenses Total
- 3.52
- Total Operating Expense
- 299.17
- Operating Income
- 134.03
- Net Income Before Taxes
- 140.42
- Net Income
- 88.41
- Diluted Normalized EPS
- 17.49
- Period
- 2020
- Total Assets
- 469.33
- Total Liabilities
- 102.67
- Total Equity
- 366.66
- Tangible Book Valueper Share Common Eq
- 50.2
- Period
- 2020
- Cashfrom Operating Activities
- 167.63
- Cashfrom Investing Activities
- 0.95
- Cashfrom Financing Activities
- -164.78
- Net Changein Cash
- 3.8
- Period
- 2019
- Total Revenue
- 402.91
- Selling/ General/ Admin Expenses Total
- 135.99
- Depreciation/ Amortization
- 26.17
- Other Operating Expenses Total
- 2.13
- Total Operating Expense
- 274.82
- Operating Income
- 128.09
- Net Income Before Taxes
- 138.06
- Net Income
- 85.14
- Diluted Normalized EPS
- 15.79
- Period
- 2019
- Total Assets
- 474.72
- Total Liabilities
- 39.6
- Total Equity
- 435.12
- Tangible Book Valueper Share Common Eq
- 61.86
- Period
- 2019
- Cashfrom Operating Activities
- 100.31
- Cashfrom Investing Activities
- -11.59
- Cashfrom Financing Activities
- -93.63
- Net Changein Cash
- -4.91
- Period
- 2018
- Total Revenue
- 356.32
- Selling/ General/ Admin Expenses Total
- 114.5
- Depreciation/ Amortization
- 20.1
- Other Operating Expenses Total
- 1.41
- Total Operating Expense
- 225.29
- Operating Income
- 131.02
- Net Income Before Taxes
- 144.99
- Net Income
- 93.28
- Diluted Normalized EPS
- 16.64
- Period
- 2018
- Total Assets
- 478.99
- Total Liabilities
- 35.7
- Total Equity
- 443.29
- Tangible Book Valueper Share Common Eq
- 62.31
- Period
- 2018
- Cashfrom Operating Activities
- 107.03
- Cashfrom Investing Activities
- -43.22
- Cashfrom Financing Activities
- -63.88
- Net Changein Cash
- -0.06
- Period
- 2024-03-31
- Total Revenue
- 154.25
- Selling/ General/ Admin Expenses Total
- 26.57
- Depreciation/ Amortization
- 13.06
- Other Operating Expenses Total
- 47.3
- Total Operating Expense
- 133.5
- Operating Income
- 20.75
- Net Income Before Taxes
- 22.9
- Net Income
- 17.78
- Diluted Normalized EPS
- 3.54
- Period
- 2024-03-31
- Total Assets
- 643.88
- Total Liabilities
- 117.11
- Total Equity
- 526.77
- Tangible Book Valueper Share Common Eq
- 79.74
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 167.62
- Cashfrom Investing Activities
- -91.29
- Cashfrom Financing Activities
- -84.8
- Net Changein Cash
- -8.47
- Period
- 2023-12-31
- Total Revenue
- 134.74
- Selling/ General/ Admin Expenses Total
- 26.36
- Depreciation/ Amortization
- 13.47
- Other Operating Expenses Total
- 38.37
- Total Operating Expense
- 116.62
- Operating Income
- 18.12
- Net Income Before Taxes
- 19.91
- Net Income
- 15.35
- Diluted Normalized EPS
- 2.78
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 148
- Selling/ General/ Admin Expenses Total
- 27.06
- Depreciation/ Amortization
- 10.65
- Other Operating Expenses Total
- 39.78
- Total Operating Expense
- 121.13
- Operating Income
- 26.87
- Net Income Before Taxes
- 28.27
- Net Income
- 20.34
- Diluted Normalized EPS
- 3.84
- Period
- 2023-09-30
- Total Assets
- 592.69
- Total Liabilities
- 106.44
- Total Equity
- 486.25
- Tangible Book Valueper Share Common Eq
- 72.73
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 69.44
- Cashfrom Investing Activities
- 4.67
- Cashfrom Financing Activities
- -77.21
- Net Changein Cash
- -3.1
- Period
- 2023-06-30
- Total Revenue
- 134.89
- Selling/ General/ Admin Expenses Total
- 27.87
- Depreciation/ Amortization
- 9.83
- Other Operating Expenses Total
- 34.44
- Total Operating Expense
- 110.21
- Operating Income
- 24.68
- Net Income Before Taxes
- 24.9
- Net Income
- 17.3
- Diluted Normalized EPS
- 3.25
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 135.88
- Selling/ General/ Admin Expenses Total
- 28.29
- Depreciation/ Amortization
- 10.8
- Other Operating Expenses Total
- 41.15
- Total Operating Expense
- 121.99
- Operating Income
- 13.89
- Net Income Before Taxes
- 17.24
- Net Income
- 12.6
- Diluted Normalized EPS
- 2.36
- Period
- 2023-03-31
- Total Assets
- 632.72
- Total Liabilities
- 98.42
- Total Equity
- 534.3
- Tangible Book Valueper Share Common Eq
- 81.85
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 129.31
- Cashfrom Investing Activities
- -38.99
- Cashfrom Financing Activities
- -86.18
- Net Changein Cash
- 4.14
- Period
- 2022-12-31
- Total Revenue
- 128.03
- Selling/ General/ Admin Expenses Total
- 27.04
- Depreciation/ Amortization
- 10.15
- Other Operating Expenses Total
- 32.27
- Total Operating Expense
- 110.32
- Operating Income
- 17.71
- Net Income Before Taxes
- 19.73
- Net Income
- 14.73
- Diluted Normalized EPS
- 2.78
- Period
- 2022-12-31
- Total Assets
- 600.92
- Total Liabilities
- 87.18
- Total Equity
- 513.74
- Tangible Book Valueper Share Common Eq
- 77.92
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Thyrocare Technologies Technical
Moving Average
SMA
- 5 Day637.37
- 10 Day636.89
- 20 Day634.79
- 50 Day632.89
- 100 Day627.62
- 300 Day608.98
Thyrocare Technologies Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Healthcare Global Enterprises
- 373
- -1.55
- -0.41
- 401
- 306.1
- 5195.51
- Kovai Medical Centre and Hospital
- 4323
- -153.35
- -3.43
- 4777
- 2231.92
- 4730.34
- Thyrocare Technologies
- 644.7
- 4.05
- 0.63
- 722
- 511
- 3412.4
- Shalby
- 278
- 1.85
- 0.67
- 333.85
- 170
- 2979.94
- Artemis Medicare Services
- 182.9
- 4.4
- 2.46
- 199
- 117.25
- 2504.19
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Healthcare Global Enterprises
- 114.94
- 6.32
- -4.88
- -3.5
- Kovai Medical Centre and Hospital
- 26.72
- 5.4
- 19.28
- 12.23
- Thyrocare Technologies
- 48.44
- 6.52
- 21.96
- 19.56
- Shalby
- 34.94
- 2.91
- 6.37
- 8.2
- Artemis Medicare Services
- 50.59
- 5.45
- -
- 4.59
Thyrocare Technologies Shareholding
Shareholding Pattern
*Promoter pledging: 71.11%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 14-May-24
- Audited Results & Final Dividend
- 01-Feb-24
- Quarterly Results
- 31-Oct-23
- Quarterly Results
- 01-Aug-23
- Quarterly Results
- 23-May-23
- Audited Results
- 07-Apr-23
- Interim Dividend
- 03-Feb-23
- Quarterly Results
- 11-Nov-22
- Quarterly Results
- 01-Aug-22
- Quarterly Results
- 29-Apr-22
- Audited Results & Dividend
- Meeting Date
- Announced on
- Purpose
- 10-Aug-23
- 14-Jul-23
- AGM
- 26-Jun-21
- 07-Jun-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 14-May-24
- -
- -
- 18
- 10-Apr-23
- 20-Apr-23
- 20-Apr-23
- 18
- 02-May-22
- 12-May-22
- 11-May-22
- 15
- 10-May-21
- -
- 17-Jun-21
- 15
![No data](https://www.livemint.com/lm-img/dev/null-data.png)
![No data](https://www.livemint.com/lm-img/dev/null-data.png)
![No data](https://www.livemint.com/lm-img/dev/null-data.png)